{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:01:54Z","timestamp":1792674114953,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.vaccine.2008.11.011","type":"journal-article","created":{"date-parts":[[2008,11,20]],"date-time":"2008-11-20T16:50:42Z","timestamp":1227199842000},"page":"530-541","source":"Crossref","is-referenced-by-count":90,"title":["Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge"],"prefix":"10.1016","volume":"27","author":[{"given":"Joel R.","family":"Haynes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Dokken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Cawthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bigger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen G.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"39\u201340","key":"10.1016\/j.vaccine.2008.11.011_bib1","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1016\/j.vaccine.2007.07.027","article-title":"Influenza vaccine: the challenge of antigenic drift","volume":"25","author":"Carrat","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.011_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.immuni.2005.12.005","article-title":"Development of effective vaccines against pandemic influenza","volume":"24","author":"Subbarao","year":"2006","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.011_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nri2054","article-title":"Scientific barriers to developing vaccines against avian influenza viruses","volume":"7","author":"Subbarao","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.11.011_bib4","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1371\/journal.ppat.0030040","article-title":"H5N1 viruses and vaccines","volume":"3","author":"Subbarao","year":"2007","journal-title":"PLoS Pathog"},{"issue":"21","key":"10.1016\/j.vaccine.2008.11.011_bib5","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1056\/NEJMp068205","article-title":"H5N1 influenza\u2014continuing evolution and spread","volume":"355","author":"Webster","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2008.11.011_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ni1343","article-title":"Influenza and the challenge for immunology","volume":"7","author":"Doherty","year":"2006","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.11.011_bib7","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJMoa044307","article-title":"Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma","volume":"352","author":"de Jong","year":"2005","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2008.11.011_bib8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa040419","article-title":"Avian influenza A (H5N1) in 10 patients in Vietnam","volume":"350","author":"Tran","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2008.11.011_bib9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3201\/eid1305.060572","article-title":"Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans","volume":"13","author":"Uiprasertkul","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.011_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa044021","article-title":"Probable person-to-person transmission of avian influenza A (H5N1)","volume":"352","author":"Ungchusak","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.011_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1099-1654(199910\/12)9:4<237::AID-RMV252>3.0.CO;2-G","article-title":"The development of live attenuated cold-adapted influenza virus vaccine for humans","volume":"9","author":"Maassab","year":"1999","journal-title":"Rev Med Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.011_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0042-6822(02)00035-1","article-title":"Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A\/Ann Arbor\/6\/60","volume":"306","author":"Jin","year":"2003","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.011_bib13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/JCM.38.2.839-845.2000","article-title":"Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial","volume":"38","author":"Cha","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.11.011_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.vaccine.2008.11.011_bib15","doi-asserted-by":"crossref","first-page":"11538","DOI":"10.1128\/JVI.74.24.11538-11547.2000","article-title":"Influenza virus matrix protein is the major driving force in virus budding","volume":"74","author":"Gomez-Puertas","year":"2000","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.011_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/vim.2005.18.244","article-title":"Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge","volume":"18","author":"Galarza","year":"2005","journal-title":"Viral Immunol"},{"issue":"50","key":"10.1016\/j.vaccine.2008.11.011_bib17","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/j.vaccine.2005.07.098","article-title":"Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB\/c mice","volume":"23","author":"Pushko","year":"2005","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2008.11.011_bib18","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1016\/j.vaccine.2007.02.059","article-title":"Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza","volume":"25","author":"Pushko","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2008.11.011_bib19","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/JVI.02052-06","article-title":"Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus","volume":"81","author":"Quan","year":"2007","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2008.11.011_bib20","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/j.vaccine.2007.01.106","article-title":"Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin","volume":"25","author":"Bright","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.011_bib21","doi-asserted-by":"crossref","first-page":"e1501","DOI":"10.1371\/journal.pone.0001501","article-title":"Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle","volume":"3","author":"Bright","year":"2008","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2008.11.011_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/vim.2007.0027","article-title":"A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1)","volume":"20","author":"Matassov","year":"2007","journal-title":"Viral Immunol"},{"issue":"26","key":"10.1016\/j.vaccine.2008.11.011_bib23","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.vaccine.2008.03.055","article-title":"A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs","volume":"26","author":"Quan","year":"2008","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2008.11.011_bib24","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1128\/JVI.00361-07","article-title":"Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles","volume":"81","author":"Chen","year":"2007","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.011_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.virusres.2004.08.007","article-title":"Retrovirus budding","volume":"106","author":"Demirov","year":"2004","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.011_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0092-8674(89)90873-8","article-title":"Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells","volume":"59","author":"Gheysen","year":"1989","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.vaccine.2008.11.011_bib27","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1128\/JVI.64.6.2653-2659.1990","article-title":"Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system","volume":"64","author":"Haffar","year":"1990","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.011_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/aid.1991.7.17","article-title":"Production of immunogenic HIV-1 viruslike particles in stably engineered monkey cell lines","volume":"7","author":"Haynes","year":"1991","journal-title":"AIDS Res Hum Retrovir"},{"issue":"22","key":"10.1016\/j.vaccine.2008.11.011_bib29","doi-asserted-by":"crossref","first-page":"8964","DOI":"10.1073\/pnas.86.22.8964","article-title":"Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector","volume":"86","author":"Karacostas","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.vaccine.2008.11.011_bib30","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1128\/JVI.66.7.4003-4012.1992","article-title":"Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine","volume":"66","author":"Rovinski","year":"1992","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2008.11.011_bib31","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1073\/pnas.83.19.7246","article-title":"Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus","volume":"83","author":"Rein","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.vaccine.2008.11.011_bib32","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1128\/JVI.63.5.2370-2373.1989","article-title":"Unmyristylated Moloney murine leukemia virus Pr65gag is excluded from virus assembly and maturation events","volume":"63","author":"Schultz","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.11.011_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1743-422X-3-73","article-title":"Caveolin-1 interacts with the Gag precursor of murine leukaemia virus and modulates virus production","volume":"3","author":"Yu","year":"2006","journal-title":"Virol J"},{"issue":"25","key":"10.1016\/j.vaccine.2008.11.011_bib34","doi-asserted-by":"crossref","first-page":"14610","DOI":"10.1073\/pnas.2235620100","article-title":"Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion","volume":"100","author":"Takeda","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1016\/j.vaccine.2008.11.011_bib35","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1093\/emboj\/16.18.5501","article-title":"Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain","volume":"16","author":"Scheiffele","year":"1997","journal-title":"EMBO J"},{"issue":"10","key":"10.1016\/j.vaccine.2008.11.011_bib36","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1128\/JVI.78.10.5258-5269.2004","article-title":"Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding","volume":"78","author":"Barman","year":"2004","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2008.11.011_bib37","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1128\/JVI.74.14.6538-6545.2000","article-title":"Analysis of the transmembrane domain of influenza virus neuraminidase, a type II transmembrane glycoprotein, for apical sorting and raft association","volume":"74","author":"Barman","year":"2000","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.011_bib38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0042-6822(03)00372-6","article-title":"Enhancement of mucosal immune responses by chimeric influenza HA\/SHIV virus-like particles","volume":"313","author":"Guo","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.11.011_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1743-422X-3-70","article-title":"Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses","volume":"3","author":"Szecsi","year":"2006","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2008.11.011_bib40","unstructured":"Guide for the care and use of laboratory animals. http:\/\/wwwnapedu\/readingroom\/books\/labrats\/."},{"key":"10.1016\/j.vaccine.2008.11.011_bib41","unstructured":"WHO manual on animal influenza diagnosis and surveillance. http:\/\/wwwwhoint\/vaccine_research\/diseases\/influenza\/WHO_manual_on_animal-diagnosis_and_surveillance_2002_5pdf."},{"issue":"7","key":"10.1016\/j.vaccine.2008.11.011_bib42","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/es60130a004","article-title":"Trimmed Spearman\u2013Karber method for estimating median lethal concentrations in toxicity bioassays","volume":"11","author":"Hamilton","year":"1977","journal-title":"Environ Sci Technol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.11.011_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2004.02.019","article-title":"Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A\/Duck\/Singapore\/97 vaccine","volume":"103","author":"Stephenson","year":"2004","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.011_bib44","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1128\/JVI.79.4.2191-2198.2005","article-title":"Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004","volume":"79","author":"Govorkova","year":"2005","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.011_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/505225","article-title":"Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge","volume":"194","author":"Govorkova","year":"2006","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.11.011_bib46","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1128\/JVI.79.5.2847-2858.2005","article-title":"Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus","volume":"79","author":"Abe","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.11.011_bib47","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4049\/jimmunol.171.3.1133","article-title":"Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice","volume":"171","author":"Abe","year":"2003","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.11.011_bib48","doi-asserted-by":"crossref","first-page":"9944","DOI":"10.1128\/JVI.73.12.9944-9951.1999","article-title":"Baculovirus stimulates antiviral effects in mammalian cells","volume":"73","author":"Gronowski","year":"1999","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.11.011_bib49","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1128\/JVI.77.11.6265-6273.2003","article-title":"Palmitoylation of the Autographa californica multicapsid nucleopolyhedrovirus envelope glycoprotein GP64: mapping, functional studies, and lipid rafts","volume":"77","author":"Zhang","year":"2003","journal-title":"J Virol"},{"issue":"36","key":"10.1016\/j.vaccine.2008.11.011_bib50","doi-asserted-by":"crossref","first-page":"12915","DOI":"10.1073\/pnas.0506416102","article-title":"Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines","volume":"102","author":"Hoffmann","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.011_bib51","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1371\/journal.pone.0001401","article-title":"Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine","volume":"3","author":"Baras","year":"2008","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.011_bib52","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.011_bib53","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1371\/journal.pmed.0040091","article-title":"Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?","volume":"4","author":"Gillim-Ross","year":"2007","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.011_bib54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/viro.1998.9523","article-title":"Requirement for GP64 to drive efficient budding of Autographa californica multicapsid nucleopolyhedrovirus","volume":"254","author":"Oomens","year":"1999","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08015211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08015211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T15:45:48Z","timestamp":1589125548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08015211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0264410X08015211"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}